Form 4: Harmony Biosciences CFO Sandip Kapadia Reports Stock Transactions

Sandip Kapadia, CFO of Harmony Biosciences Holdings, Inc., reports the vesting of restricted stock units and subsequent stock sales to cover tax obligations.

Summary

• On March 29, 2025, Sandip Kapadia, the CFO of Harmony Biosciences Holdings, Inc., had 15,000 restricted stock units vest.
• Following the vesting, Kapadia disposed of 8,014 shares of common stock at a price of $33.19 to cover income tax withholdings.
• After these transactions, Kapadia directly owns 6,986 shares of Harmony Biosciences Holdings, Inc. common stock.
• The reported transactions relate to restricted stock units previously granted on March 29, 2021, with vesting occurring over several years.

Sentiment

Score: 5

Explanation: This is a routine filing related to executive compensation and stock transactions, with no indication of positive or negative sentiment.

Future Outlook

25% of the underlying shares from the restricted stock units granted on March 29, 2021, vested on March 29, 2025.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company's stock.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transaction, Restricted Stock Units, Harmony Biosciences, Sandip Kapadia, CFO